Skip to main content
Atrás
Watch Compare

TENAX THERAPEUTICS, INC.

Calidad de datos: 100%
TENX
NASDAQ Manufacturing Chemicals
$14.71
▲ $0.21 (1.43%)
Cap. Mercado: 260.72 M
6 months return
—
Momentum
Neutral
ROE
-52.72%

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -35.80 M

Price History

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-52.72%
Above sector avg (-54.44%)
ROIC-44.65%
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
N/A
Current Ratio15.58
Interest CoverageN/A

Valoración

PE (TTM|NTM)
-4.96 | -9.87
Below sector avg (-1.49)
P/B Ratio2.71
EV/EBITDAN/A
Dividend YieldN/A

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1385 pares)
Métrica Acción Mediana del Sector
P/E -5.0 -1.5
P/B 2.7 1.6
ROE % -52.7 -54.4
Net Margin % — -41.5
Rev Growth 5Y % — 1.7
D/E — 0.3

Precio Objetivo de Analistas

7 analistas

Consenso de analistas: objetivo medio vs precio actual y calificación.

Buy
Actual
$14.71
+101.1%
Objetivo
$29.57
$20.00
$30.00
$35.00
Pronóstico
P/E Futuro -9.87
EPS Futuro -$1.46
Ingresos Est. 0.0

Estimaciones de Ganancias

Pronósticos de EPS e ingresos por período. Anual = años fiscales; trimestral = próximos trimestres.

Período EPS Est. Ingresos Est. Analistas
FY2027 -$1.46
-$1.82 – -$1.27
0.0 5
FY2026 -$1.56
-$1.83 – -$1.36
0.0 6

Sorpresas de Ganancias

Últimos 4 trimestres
Trimestre EPS Est. EPS Real Sorpresa
Q42025 -$0.42 -$0.38 +8.4%
Q32025 -$1.12 -$0.40 +64.4%
Q22025 -$0.45 -$0.27 +39.7%
Q12025 -$0.41 -$0.28 +31.7%

ETFs Holding This Stock

BRUSX BRUSX
0.60% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0.0 Net Income (TTM) -52.60 M
ROE -52.72% ROA -50.41%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -35.80 M
ROIC -44.65% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 15.58
Interest Coverage N/A Asset Turnover 0.00
Working Capital 96.21 M Tangible Book Value 96.21 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -4.96 Forward P/E -9.87
P/B Ratio 2.71 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -13.73%
Market Cap 260.72 M Enterprise Value 161.32 M
Per Share
EPS (Diluted TTM) -1.34 Revenue / Share 0.00
FCF / Share -2.08 OCF / Share -2.08
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 68.06%
SBC-Adj. FCF -50.17 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0.0 0.0 — — —
Net Income -52.60 M -17.60 M 7.71 M -11.05 M -32.47 M
EPS (Diluted) -1.34 -1.15 — — —
Gross Profit — — — — —
Operating Income -56.39 M -19.49 M 8.23 M -11.05 M 32.73 M
EBITDA — — — — —
R&D Expenses 32.67 M 12.71 M 3.23 M 5.38 M 25.15 M
SG&A Expenses — — — — 7.58 M
D&A — 0.0 7,570.0 5,143.0 4,116.0
Interest Expense 0.0 23,000.0 23,967.0 4,443.0 949.0
Income Tax 0.0 0.0 — 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 104.23 M 96.69 M 11.68 M 3.40 M 5.99 M
Total Liabilities 7.16 M 4.69 M 3.59 M 1.91 M 1.75 M
Shareholders' Equity 97.07 M 91.99 M 8.10 M 1.49 M 4.24 M
Total Debt — — — — —
Cash & Equivalents 97.60 M 94.90 M — 2.12 M 5.58 M
Current Assets 104.23 M 96.69 M 11.68 M 3.21 M 5.69 M
Current Liabilities 7.16 M 4.69 M 3.59 M 1.85 M 1.56 M